 Latest Articles
|
Building for big pharma
With acquisition the most likely exit for today's biotech investors, it pays to keep current with the tastes of pharmaceutical firms when launching a venture.
|
Startups on the Menu: EnBiotix
|
Innovative startups 2012
|
View more articles 
|
Trade Secrets Blog
|
The Bioentrepreneur blog, Trade Secrets, boasts contributors from around the globe, providing regular insight and commentary from those helping build the world's biotechnology sectors.
|
Podcast
|
Nature Biotechnology's First Rounders podcast is a series of conversations with founders, financers and developers from biotech's past, present and future.
|
Also visit the Bioentrepreneur portal http://www.nature.com/bioent/ for an update on the latest events focusing on life science entrepreneurship around the world.
|
Advertisement |
 |
Biopharma Dealmakers
Biotech in China
The latest issue of Biopharma Dealmakers highlights China's emerging biotech industry and contains this special feature:
Enter the Dragon - China's Biopharmaceutical Clusters
Click here to download this issue for free! | |
|
|
You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department
For print subscription enquiries, please contact our subscription department
For other enquiries, please contact our feedback department
Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston |
|
No comments:
Post a Comment